Bisphosphonate-Induced Osteonecrosis of the Jaw 32 Months After Interruption of Zoledronate in a Patient With Multiple Myeloma

Journal of Oral and Maxillofacial Surgery

Volumn 68, Issue 5, 2010, Pages 1179-1182

  Del Conte, Alessandro ^a   Bernardeschi, Paolo ^a   La Ferla, Fabio ^b   Turrisi, Gina ^a   D'Alessandro, Michelina ^a   Montagnani, Francesco ^a   Fiorentini, Giammaria ^a  

^a SAN GIUSEPPE HOSPITAL   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE; DEXAMETHASONE; MELPHALAN; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; THALIDOMIDE; ZOLEDRONIC ACID;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; GERIATRIC PATIENT; HUMAN; JAW DISEASE; JAW OSTEONECROSIS; MAXILLA; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; TOOTH EXTRACTION; TREATMENT OUTCOME; ULCER HEALING;

AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMIDAZOLES; MAXILLARY DISEASES; MULTIPLE MYELOMA; OROANTRAL FISTULA; OSTEONECROSIS;

EID: 77950858969     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.08.005     Document Type: Article

References (7)

1. Rosen L.S., Gordon D., Kaminski M., et al. Long-term efficacy and safety of zoledronic acid compared with pamidonate disodium in treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: A randomized, double-blind, multicenter, comparative trial. Cancer 98 (2003) 1735
2. Kyle R.A., Yee G.C., Somerfield M.R., et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 25 (2007) 2464
3. Migliorati C.A. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21 (2003) 4253
4. Marx R.E. Pamidronate (Aredia) and zolendronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115
5. Ruggiero S.L., Mehrotra B., Rosenberg T.J., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527
6. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons' position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65 (2007) 369
7. Ibrahim T., Barbati F., Giorgio-Marrano G., et al. Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: A retrospective study. Oncologist 13 (2008) 330